metaflumizone (iso); (ez)-2-[2-(4-cyanophenyl)-1-(î±,î±,î± -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [e-isomer ≥ 90 %, z-isomer ≤ 10 % relative content] [1] (e)-2-[2-(4-cyanophenyl)-1-(î±,î±,î± -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2]

Is metaflumizone (iso); (ez)-2-[2-(4-cyanophenyl)-1-(î±,î±,î± -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [e-isomer ≥ 90 %, z-isomer ≤ 10 % relative content] [1] (e)-2-[2-(4-cyanophenyl)-1-(î±,î±,î± -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2] safe?

metaflumizone (iso); (ez)-2-[2-(4-cyanophenyl)-1-(î±,î±,î± -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [e-isomer ≥ 90 %, z-isomer ≤ 10 % relative content] [1] (e)-2-[2-(4-cyanophenyl)-1-(î±,î±,î± -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2] carries significant published concerns (hormone disruption).

Documented concerns

Related ingredients

Ingredients with a similar role or shared type of concern — useful for comparing what's on your label.

• 4-Methylbenzylidene Camphor
• Butylphenyl Methylpropional
• Cyclotetrasiloxane
• Dibutyl Phthalate
• Lead Acetate
• Toluene